Market Research
Hub (MRH) has added the report ‘Active
Pharmaceutical Ingredient Market: Global Industry Analysis, Size, Share,
Growth, Trends and Forecast 2015 - 2023’ to its offering. This report provides
a comprehensive evaluation of the market and incorporates an extensive quality
analysis of the major dynamics impacting the development of the global
pharmaceutical ingredient market. The market attractiveness evaluation on the
basis of geography has also been encapsulated in the report. In addition, the
report throws light on the event impact evaluation for the active pharmaceutical
ingredient market.

The first section of the report presents an
introduction to the global active pharmaceutical ingredients market. This section
comprises the definition of active pharmaceutical ingredients. An active
pharmaceutical ingredients (APIs) are a combination of substances or a single
substance that is utilized in a finished pharmaceutical product (FPP) and is
aimed to furnish any kind of pharmacological activity. They are also utilized
to have a direct impact in the cure, mitigation, diagnosis, prevention or
treatment of a disease. APIs are highly utilized for manufacturing safe and
effective medicines and are bulk products employed as raw materials in
formulations.

Moving next, the dynamics impacting the development
of the market have been presented. The rising expenditures in healthcare and
the swiftly growing geriatric population are the major factors stimulating the
growth of the active pharmaceutical ingredient market. In addition, the
increasing proliferation of Abbreviated New Drug Applications (ANDA) in the
past few years will further augment the development of this market.
Furthermore, the development of the Asia Pacific and the Rest of the World
(RoW) healthcare markets and the patent expiry of the key biological drugs
within the EU and the U.S. are the key opportunities in the market. On the
other hand, the unfavorable regulatory policies imposed globally may inhibit
the development of the market in the coming years.

The next section of the report throws light on the
segmentation of the active pharmaceutical ingredient market. On the basis of
manufacturing process, the market is segmented into contract manufacturing and
captive manufacturing. In terms of API type, the report segments the market
into biological API and synthetic chemical API. By drug type, the report
segments the market into generic, branded, and OTC prescription drugs. By
therapeutic area, the report segments the market into cardiovascular disorders,
metabolic disorders, neurological disorders, oncology, musculoskeletal
disorders, NSAIDs, and other therapeutics uses. Geographically, the report segments
the market into North America, Asia Pacific, Rest of Asia Pacific, Europe, and
Rest of the World (RoW).

The report suggest that the emerging players and the
already established players in the global active pharmaceutical ingredient
market can enhance their businesses in the market by the following two ways:
Firstly, by expansion of their manufacturing capacities through acquisitions
within promising geographies and secondly, by achieving cost leadership within
particular API molecules. Hence, these have emerged as major opportunity areas
in the global active pharmaceutical ingredient market.

At the end of the report, the company profiles of
the prominent players operating in the market have been presented. Some of
these players are BASF SE, Allergan plc., Boehringer Ingelheim GmbH, Dr.
Reddy's Laboratories, Cambrex Corporation, Lonza Group, Pfizer, Inc., Sandoz
(Novartis AG), and Mylan N.V., among others.

Market Research Hub (MRH) is
a next-generation reseller of research reports and analysis. MRH’s expansive
collection of market research reports has been carefully curated to help key
personnel and decision makers across industry verticals to clearly visualize
their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and
services: Objective and sound market forecasts, qualitative and quantitative
analysis, incisive insight into defining industry trends, and market share
estimates. Our reputation lies in delivering value and world-class capabilities
to our clients.